Fifty-seven percent of the respondents selected medical advances as the most important benefit, followed by environmental cleanup (16 percent), security and defense (12 percent), and improved human physical and mental abilities (11 percent). In choosing which of five nanotechnology risks it was most important to avoid, respondents’ top choice was loss of privacy due to surveillance (32 percent), followed by a nanotechnology arms race (24 percent).
(July 26, 2004) Washington, D.C.—IMAPs has chosen Michael O’Donoghue to replace Richard M. Breck as its executive director, effective September 1, 2004.